Patents by Inventor Christopher M. Owen
Christopher M. Owen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11937762Abstract: A vacuum tool configured to be removably coupled to hose or wand of a vacuum includes a body including a first end, a second end, and a first longitudinal axis extending between the first end and the second end. The vacuum tool also includes a head coupled to the first end of the body, a connection portion coupled to the second end of the body and configured to couple the body to a hose or wand of a vacuum cleaner, and a brush coupled to the head. The brush includes an elongate support defining a second axis perpendicular to the longitudinal axis of the body and configured to couple the brush to the head, and a plurality of bristles positioned on the elongate support.Type: GrantFiled: June 25, 2020Date of Patent: March 26, 2024Assignee: Milwaukee Electric Tool CorporationInventors: Kyle Reeder, Ellen M. Owens, Jonathan Lowry, Alexander J. Goodman, Christopher J. Metcalf, Scott T. Moeller
-
Publication number: 20200392208Abstract: CRISPR/CAS-related systems, compositions and methods for editing HSV-1 genes in human cells are described, as are cells and compositions including cells edited according to the same. Methods for treating HSV-related keratitis using the said CRISPR/CAS-related systems, compositions and methods are also described.Type: ApplicationFiled: July 31, 2020Publication date: December 17, 2020Applicant: EDITAS MEDICINE, INC.Inventors: Benjamin Aryeh Diner, Christopher M. Owens, Ari Friedland
-
Publication number: 20200174713Abstract: Disclosed herein is a technique to efficiently pack a print volume of 3D printers having print jobs with a large number of objects. The technique positions unique objects that adhere to a similar structural pattern more closely when the degree of variation between the objects is small. Thus, while each object is unique, a greater extent of similarity between the objects causes a given group of objects to be positioned more closely to one another in the print area of the 3D printer.Type: ApplicationFiled: February 3, 2020Publication date: June 4, 2020Inventors: Colin M. Lawson, Michael C. Salmon, Carly M. Fennell, Christopher W. Bellamy, Amy J. Vanden Eynde, Christopher M. Owen, Shamil Hargovan, Hsiao Ting Lin, Aron Tremble
-
Patent number: 10552095Abstract: Disclosed herein is a technique to efficiently pack a print volume of 3D printers having print jobs with a large number of objects. The technique positions unique objects that adhere to a similar structural pattern more closely when the degree of variation between the objects is small. Thus, while each object is unique, a greater extent of similarity between the objects causes a given group of objects to be positioned more closely to one another in the print area of the 3D printer.Type: GrantFiled: November 15, 2018Date of Patent: February 4, 2020Assignee: Wiivv Wearables Inc.Inventors: Colin M. Lawson, Michael C. Salmon, Carly M Fennell, Christopher W. Bellamy, Amy J. Vanden Eynde, Christopher M. Owen, Shamil N. Hargovan, Hsiao Ting Lin, Aron Tremble
-
Patent number: 9060971Abstract: The present invention relates to pharmaceutical agents administered to a subject either in combination or in series for the treatment of a flaviviridae viral infection, for example, hepatitis C virus (HCV), wherein treatment comprises administering a compound effective to inhibit the function of the HCV NS5A protein and an additional compound or combinations of compounds having anti-HCV activity.Type: GrantFiled: August 5, 2010Date of Patent: June 23, 2015Assignee: Enanta Pharmaceuticals, Inc.Inventors: Yat Sun Or, Christopher M. Owens, Bradley B. Brasher, Yao-Ling Qiu, Lijuan Jiang
-
Patent number: 8309697Abstract: The invention provides novel TRIM polypeptides, proteins, and nucleic acid molecules. In addition to isolated, full-length TRIM proteins, the invention further provides isolated TRIM fusion proteins, antigenic peptides and anti-TRIM antibodies. The invention also provides TRIM nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced and non-human transgenic animals in which an TRIM gene has been introduced or disrupted. The present invention also provides methods and compositions for the diagnosis and treatment of viral infection and/or replication, e.g., HIV infection. The invention further provides methods for identifying a compound capable of treating or preventing viral infection and/or replication, e.g., HIV infection and AIDS. In addition, the invention provides a method for treating a subject having a viral infection and/or replication, e.g.Type: GrantFiled: January 19, 2010Date of Patent: November 13, 2012Assignee: Dana-Farber Cancer Institute, Inc.Inventors: Joseph Sodroski, Matthew Stremlau, Christopher M. Owens
-
Publication number: 20110217261Abstract: The present invention relates to pharmaceutical agents administered to a subject either in combination or in series for the treatment of a flaviviridae viral infection, for example, hepatitis C virus (HCV), wherein treatment comprises administering a compound effective to inhibit the function of the HCV NS5A protein and an additional compound or combinations of compounds having anti-HCV activity.Type: ApplicationFiled: August 5, 2010Publication date: September 8, 2011Inventors: Yat Sun Or, Christopher M. Owens, Bradley B. Brasher, Yao-Ling Qiu, Lijuan Jiang
-
Publication number: 20100129438Abstract: The invention provides novel TRIM polypeptides, proteins, and nucleic acid molecules. In addition to isolated, full-length TRIM proteins, the invention further provides isolated TRIM fusion proteins, antigenic peptides and anti-TRIM antibodies. The invention also provides TRIM nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced and non-human transgenic animals in which an TRIM gene has been introduced or disrupted. The present invention also provides methods and compositions for the diagnosis and treatment of viral infection and/or replication, e.g., HIV infection. The invention further provides methods for identifying a compound capable of treating or preventing viral infection and/or replication, e.g., HIV infection and AIDS. In addition, the invention provides a method for treating a subject having a viral infection and/or replication, e.g.Type: ApplicationFiled: January 19, 2010Publication date: May 27, 2010Applicant: Dana-Farber Cancer Institute, Inc.Inventors: Joseph Sodroski, Matthew Stremlau, Christopher M. Owens
-
Publication number: 20100092479Abstract: The present invention features compositions, methods, and kits useful in the treatment of viral diseases. In certain embodiments, the viral disease is caused by a single stranded RNA virus, a flaviviridae virus, or a hepatic virus. In particular embodiments, the viral disease is viral hepatitis (e.g., hepatitis A, hepatitis B, hepatitis C, hepatitis D, hepatitis E).Type: ApplicationFiled: August 17, 2009Publication date: April 15, 2010Applicant: CombinatoRx (Singapore) Pte. Ltd.Inventors: Lisa M. Johansen, Christopher M. Owens
-
Patent number: 7659382Abstract: The invention provides novel TRIM polypeptides, proteins, and nucleic acid molecules. In addition to isolated, full-length TRIM proteins, the invention further provides isolated TRIM fusion proteins, antigenic peptides and anti-TRIM antibodies. The invention also provides TRIM nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced and non-human transgenic animals in which an TRIM gene has been introduced or disrupted. The present invention also provides methods and compositions for the diagnosis and treatment of viral infection and/or replication, e.g., HIV infection. The invention further provides methods for identifying a compound capable of treating or preventing viral infection and/or replication, e.g., HIV infection and AIDS. In addition, the invention provides a method for treating a subject having a viral infection and/or replication, e.g.Type: GrantFiled: August 25, 2006Date of Patent: February 9, 2010Assignee: Dana-Farber Cancer Institute, Inc.Inventors: Joseph Sodroski, Matthew Stremlau, Christopher M. Owens
-
Publication number: 20100009970Abstract: The present invention features compositions, methods, and kits useful in the treatment of viral diseases. In certain embodiments, the viral disease is caused by a single stranded RNA virus, a flaviviridae virus, or a hepatic virus. In particular embodiments, the viral disease is viral hepatitis (e.g., hepatitis A, hepatitis B, hepatitis C, hepatitis D, hepatitis E) and the agent or combination of agents includes sertraline, a sertraline analog, UK-416244, or a UK-416244 analog. Also featured are screening methods for identification of novel compounds that may be used to treat a viral disease.Type: ApplicationFiled: March 18, 2009Publication date: January 14, 2010Applicant: Combinatorx (Singapore) Pte. Ltd.Inventors: Lisa M. Johansen, Christopher M. Owens, Christina Mawhinney, Todd W. Chappell, Alexander T. Brown, Michael G. Frank, Michael A. Foley, Ralf Altmeyer, Yu Chen
-
Publication number: 20080161324Abstract: The present invention features compositions, methods, and kits useful in the treatment of viral diseases. In certain embodiments, the viral disease is caused by a single stranded RNA virus, a flaviviridae virus, or a hepatic virus. In particular embodiments, the viral disease is viral hepatitis (e.g., hepatitis A, hepatitis B, hepatitis C, hepatitis D, hepatitis E). Also featured are screening methods for identification of novel compounds that may be used to treat a viral disease.Type: ApplicationFiled: September 13, 2007Publication date: July 3, 2008Inventors: Lisa M. Johansen, Christopher M. Owens, Christina Mawhinney, Todd W. Chappell, Alexander T. Brown, Michael G. Frank, Ralf Altmeyer
-
Patent number: 7363677Abstract: A shoe brush is disclosed. An illustrative embodiment of the shoe brush includes a hitch bar, a brush unit provided on the hitch bar and at least one brush provided on the brush unit.Type: GrantFiled: August 9, 2006Date of Patent: April 29, 2008Inventor: Christopher M. Owens